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ABSTRACT: The genetic material of viruses is protected by
protein shells that are assembled from a large number of subunits
in a process that is efficient and robust. Many of the mechanistic
details underpinning efficient assembly of virus capsids are still
unknown. The assembly mechanism of hepatitis B capsids has been
intensively researched using a truncated core protein lacking the C-
terminal domain responsible for binding genomic RNA. To resolve
the assembly intermediates of hepatitis B virus (HBV), we studied
the formation of nucleocapsids and empty capsids from full-length
hepatitis B core proteins, using time-resolved small-angle X-ray
scattering. We developed a detailed structural model of the HBV
capsid assembly process using a combination of analysis with
multivariate curve resolution, structural modeling, and Bayesian ensemble inference. The detailed structural analysis supports
an assembly pathway that proceeds through the formation of two highly populated intermediates, a trimer of dimers and a
partially closed shell consisting of around 40 dimers. These intermediates are on-path, transient and efficiently convert into
fully formed capsids. In the presence of an RNA oligo that binds specifically to the C-terminal domain the assembly proceeds
via a similar mechanism to that in the absence of nucleic acids. Comparisons between truncated and full-length HBV capsid
proteins reveal that the unstructured C-terminal domain has a significant impact on the assembly process and is required to
obtain a more complete mechanistic understanding of HBV capsid formation. These results also illustrate how combining
scattering information from different time-points during time-resolved experiments can be utilized to derive a structural model
of protein self-assembly pathways.
KEYWORDS: hepatitis B virus, capsid assembly, time-resolved, small-angle scattering, electron microscopy, multivariate curve resolution,
Bayesian statistics
One essential step during viral−host infection is theencapsulation of the nucleic acids necessary for viralreproduction by a protein shell. Formation of this
shell is one of the most complex processes in biology and
typically involves the spontaneous self-assembly of hundreds of
individual and identical subunits. The final assembled protein
shell, or capsid, must also selectively transport and deliver its
cargo to infect new host cells, where this cycle can be repeated.
As the protein capsid serves a vital role not only in viral
maturation but also for cellular recognition, a better under-
standing of these mechanisms is desirable for both the
development of antiviral drugs1 and other applications such
as vaccine development,2 biotechnology,3 and protein design/
engineering.
Our understanding of the mechanism for capsid formation
has primarily been advanced through assembly experiments in
vitro.4 In successful examples, capsid proteins were purified
under conditions where disassembly was favored and the
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resulting stable subunits were used in kinetic experiments
where self-assembly was triggered by changes in solution
conditions (pH, temperature, ionic strength, etc.) that promote
associations between protein subunits. The hepatitis B virus
(HBV) mature capsid is composed of 120 dimers of core
protein (Cp) forming icosahedral structures in vivo with T = 4
quasi-symmetry. A small fraction (∼5%) of T = 3 particles,
consisting of 90 dimers, has also been observed in vivo.5 The
native Cp monomer contains 183 amino acids, with a large
disordered C-terminal arginine rich domain (ARD) that binds
to pregenomic RNA (pgRNA). A truncated variant containing
the first 149 residues (Cp149) lacking the RNA binding
domain was capable of assembling into T = 4 capsids (Figure
1).6 In vitro self-assembly of Cp149 has been demonstrated by
increasing the ionic strength, subunit concentration, or
temperature.6,7 Cp149 capsid formation was described by a
classical nucleation−elongation mechanism,7,8 occurring in
three steps. Capsid formation is initiated through the
formation of a nucleus.8,9 This nucleus is then extended
through an “elongation” phase in which capsid subunits are
added to the growing assembly.6 Finally, the incorporation of
the last subunit completes the capsid.10 Cp149 has been
suggested to form a trimer of dimers as a nucleus,6 while the
elongation rapidly proceeds through an ensemble of lowly
populated intermediates. Kinetic data from light scattering,6
mass spectrometry,10−14 and small-angle X-ray scattering
(SAXS)15 have provided a multifaceted picture of the
formation of the Cp149 capsid. Much less is known about
the assembly pathway of the full-length protein. Capsids have
been reassembled from disassembled containers,16 but the
limited solubility of Cp at physiological conditions16 has made
kinetic experiments more complex to carry out. Cp assembly
was monitored indirectly in vitro using single-molecule
fluorescence correlation spectroscopy and following the
rotational correlation time of fluorescently labeled pgRNA
during encapsulation.17
Time-resolved small-angle X-ray scattering (TR-SAXS) is a
powerful method to study the mechanism of virus self-
assembly.18−23 Macromolecular complexes can be studied over
broad length scales (tens to hundreds of angstroms) and at
relatively fast time scales (approaching milliseconds) to
provide three-dimensional structural information (size and
shape) about the molecular assemblies in solution. Downsides
of TR-SAXS include orientational averaging of the scattering
signal resulting in limited structural resolution and the fact that
scattering from the sample is an ensemble average over all
species found in solution. Hence, to develop a kinetic and
structural model of the self-assembly process from TR-SAXS,
experimental data must be deconvoluted into components and
combined with additional information from three-dimensional
structures.
In this study we developed a statistical methodology based
on multivariate curve resolution to identify basis spectra from
TR-SAXS measurements and an approach to predict the
structural composition along the assembly trajectory of the full-
length HBV core protein, using Bayesian ensemble inference.
To characterize the capsid assembly mechanism, we first
established experimental conditions that allowed for the
controlled self-assembly of virus-like particles (VLPs) at high
Cp concentrations, enabling kinetic measurements of assembly
reactions. We then carried out kinetic experiments using
stopped flow coupled to TR-SAXS. TR-SAXS was performed
in both the presence and absence of RNA to determine the
effect of RNA binding to capsid subunits on assembly kinetics.
The selected RNA had previously been identified as forming
stem loops that have sequence-specific interactions with the
hepatitis B core protein dimers.17 Interpretation of the data
suggested that the formation of empty (RNA-removed)
capsids proceeds along a pathway involving two highly
populated intermediate states: an early buildup of trimers of
dimers followed by the formation of a late intermediate
consistent with large, partial shells. The binding of RNA to the
capsid proteins did not significantly alter the self-assembly
pathway. Our results demonstrate that full-length core proteins
assemble with a significantly different mechanism compared to
Cp149, which currently serves as the de facto model system for
HBV capsid assembly.
RESULTS AND DISCUSSION
Assembly competent dimers of full-length Cp (Cp185,
Supplementary Figures 1 and 2) were produced by disassembly
of recombinantly expressed VLPs with guanidine hydro-
Figure 1. Structural arrangement and subunit organization of the HBV T = 4 viral capsid. (A) A Cp dimer in red and yellow is shown in the
context of the T = 4 Cp149 capsid (from PDB code 1QGT24), with dashed lines indicating the C-terminal domain. Subunits at the 5-fold
symmetry axis are shown in green with the icosahedral symmetry shown as black lines and 2-, 3-, and 5-fold symmetry centers indicated with
black symbols. (B) The RNA oligo (PS; see Results) used in the TR-SAXS.
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chloride (GuHCl), followed by purification using size-
exclusion chromatography (SEC). SAXS data recorded for
purified Cp185 under disassembly solution conditions were
consistent with a folded protein having an extended, or flexible,
portion and molecular mass of a dimer (Supplementary Figure
3 and Supplementary Table 1). To further characterize the
structure of Cp185 in solution, we compared SAXS spectra
predicted from atomistic models to the experimental data. A
dimer model extracted from the crystal structure of a Cp149 T
= 4 capsid24 did not fit well to the SAXS spectrum (data not
shown), as expected given that the C-terminal domain is not
part of the Cp149 structure. To fit a model of Cp185 to the
SAXS data, a set of structures was modeled with different
conformations of the C-terminal domain. This set of structures
was then fit to the SAXS data using a Bayesian inference
algorithm25 that balanced the fit to data with the complexity of
the ensemble model. The resulting ensemble, consisting of two
dimers each with different conformation of their C-terminal
domains, was in excellent agreement with the experimental
data (Figure 2). Collectively, the SAXS data was well described
by a model in which Cp185, under disassembly conditions, is
folded into a dimer adopting the conformation found in the
Cp149 capsid with flexible C-terminal domains. However, the
presence of very low concentrations of higher order species
cannot be fully ruled out.
Characterization of Assembled Cp185. Cp is not stable
in its dimeric form at physiological conditions in the absence of
high ionic strength provided by GuHCl or other ions.16,28 An
ionic strength corresponding to greater than 0.25 M NaCl is
also required to solubilize the assembled capsids in the absence
of RNA.16 This requirement is attributed to screening of
repulsive forces between strongly positively charged C-terminal
domains inside the shell of the empty capsid. The binding of
negatively charged RNA similarly leads to reduced repulsion
and promotes intersubunit associations. In vivo a kinase is
believed to solubilize dimers by binding to the ARD domain.
The kinase then acts as a chaperone for the dimers prior to
RNA encapsulation.28 Nonphysiological conditions were
therefore required to study the assembly pathway of full-
length Cp. To develop an efficient self-assembly protocol
suitable for stopped-flow TR-SAXS, dilution experiments were
performed in which Cp185 under disassembly conditions (1.5
M GuHCl and 0.5 M LiCl to reduce nonspecific interaction
with nucleic acids) was manually mixed 1:1 with assembly
buffer (no GuHCl and 0.25 M NaCl to maintain solubility)
and incubated for >1 h. SEC showed that capsid formation was
essentially complete under these conditions, with ∼88% mass
found in the capsid peak and no significant fraction of stable
aggregates (Supplementary Figure 4). The mixture was further
analyzed by SAXS, and scattering results were consistent with a
spherical particle, having a maximum diameter (Dmax) of 340 ±
10 Å, which is consistent with the 350 Å maximum diameter of
Cp149 particles (Supplementary Figure 5).24
How does the presence of pgRNA affect the assembly
pathway of HBV particles? It has been demonstrated that
pgRNA contains preferred sites (PSs) that function as
packaging signals.17 The PSs are regions of pgRNA that bind
preferentially to the Cp185 with high affinity and specificity.
Patel et al. identified three preferred sites in pgRNA
constituting around 30 nucleotides which were predicted to
form stem-loops with an RGAG recognition motif.17 Isolated
PS sequences were shown to induce capsid formation, and the
resulting capsid structures determined in the presence of a PS
oligo by cryo-electron microscopy (cryo-EM) demonstrated
that the RNA was bound below the 5-fold vertices of the T = 4
capsid. In this study, a synthetic 40-nucleotide-long RNA oligo
encompassing one of the identified PS sequences was used in
the capsid assembly experiments (Figure 1). Addition of this
RNA oligo to Cp185 dimers in disassembly buffer immediately
triggered capsid formation. For controlled assembly experi-
ments the RNA was therefore added to the assembly buffer,
resulting in a molar ratio between Cp185 and the PS RNA
oligo of approximately 6:1 after mixing. SEC results were
similar to the results in the absence of RNA, with an almost
(∼89%) complete conversion to capsids. SAXS data from the
reassembled nucleocapsid showed similar features to the empty
capsids, with an estimated Dmax of 330 Å (Supplementary
Table 7).
The assembled capsids were also studied by single-particle
cryo-EM after purification with SEC. Analysis of particle class
averages showed that the core particles assembled into
primarily T = 4 capsids (87.5%) with a smaller fraction of
the T = 3 state (12.5%). We determined the structure of the
empty and RNA-filled T = 4 capsids to a resolution of 5.1 and
7.5 Å, respectively. The capsid structures were consistent with
prior models of full-length core protein capsids (Figure 3 and
Supplementary Table 5).29 In the nucleocapsid the RNA was
readily identified as an additional shell of density in the interior
of the capsid.
Stopped-Flow Rapid-Mixing Assembly of Cp185. To
investigate the detailed assembly mechanism of Cp185 in the
presence and absence of RNA (PS RNA oligo) we carried out
TR-SAXS measurements using a stopped-flow mixing cell. One
Figure 2. Structural characterization of disassembled Cp185 from
the SAXS profile under disassembly buffer. These data are
consistent with a monodisperse solution of folded protein having
an extended and/or flexible domain and are well-fit by a simulated
SAXS profile (magenta line, χ2 = 2.0) corresponding to the Cp185
dimer ensemble. Fitting residuals are shown in the lower panel.
The Cp185 ensemble of structures selected via Bayesian inference
from a library of models having reconstructed C-termini is shown,
with monomers in red and yellow. The two alternative conformers
are shown in red/yellow and magenta/orange and contribute to
the SAXS profile with nearly equal populations: 0.46 (red/orange
C-termini) and 0.54 (yellow/magenta C-termini). The exper-
imental curve was analyzed to extract the radius of gyration, Rg,
and the molecular weight, Mw. The Rg was estimated to be 37.2 ±
1.6 Å. The molecular weights estimated using absolute scale-
independent methods (45.7 ± 6.9 kDa from SAXSMoW26 and 43.7
± 6.6 kDa using the Porod-invariant method27) suggested that
Cp185 exists as a dimer under these disassembly conditions.
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mixing chamber contained Cp185 in disassembly buffer, while
the second chamber contained assembly buffer with or without
PS RNA oligo. After rapid mixing the sample was analyzed by
SAXS at various time intervals to interrogate the oligomer
distribution in the mixture. In the RNA assembly reaction, the
final mixture contained a ratio of 1 PS RNA oligo per ∼6.5
Cp185 monomers.
Twenty frames were collected for the RNA-free assembly
reaction, which covered a total observation time of 58 s
(Figure 4 and Supplementary Tables 2−4). The SAXS
spectrum from the earliest time frame in the measurement
series at 60 ms was similar to that of the Cp185 dimer in the
disassembly buffer (Figure 6). After 10 s the spectra remained
essentially unchanged, suggesting that the assembly reaction
was complete at this point. Comparison of the spectrum at the
final time frame of 58 s with the steady-state SAXS spectrum
collected on capsids assembled by manual mixing (without
further purification) showed a high degree of similarity (Figure
6), indicating stopped-flow mixing produced the same capsids
as under manual mixing conditions. No signs of aggregation
were observed during the assembly. In Figure 5 progression of
the assembly reaction is illustrated by a plot of the apparent (z-
averaged30) Rg and the apparent Dmax from the SAXS spectrum
of each frame. Both metrics showed similar sigmoidal time
dependence with a half-time of around 1s and a complete
assembly after 10 s. The apparent Dmax plateaued at a value of
330 Å, which was consistent with the expected diameter of the
capsid (350 Å). The maximum apparent Dmax value was
reached slightly before the maximum apparent Rg. The
Figure 3. Comparison of cryo-EM particle reconstruction of Cp185
reassembled in the presence (red) and absence (blue) of
complementary RNA. A central cross-section of each capsid is
depicted on the right side and shown overlaid on the left.
Figure 4. Time-dependent scattering of Cp185 in the presence and absence of RNA. Left, SAXS spectra collected at various time points after
stopped-flow mixing of Cp185 in disassembly buffer with assembly buffer. Intensity I(q) as a function of scattering vector q and time. Right,
TR-SAXS of Cp185 in the presence of PS RNA oligo. The presence of two plateaus in the scattering profile in the presence of RNA is
indicated in the figure. The dotted line is for illustrative purposes only.
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intensity extrapolated to zero angle, I(0), is proportional to the
mass of the protein sample and is mainly sensitive to the
formation of high-molecular-weight species such as the T = 4
capsid. The midpoint of the transition observed for I(0)
occurred considerably later than the midpoints for Rg and Dmax.
If the assembly reaction was described by a transition between
only two states, dimer−capsid as attributed to Cp149, a
common midpoint between minimal and maximal values for
Rg, Dmax, and I(0) would have been observed. This was not the
case, suggesting that the assembly proceeds through some
highly populated intermediate states between the initial-state
dimers and final-state T = 4/T = 3 capsids. A similar picture
emerged when the intensities were plotted as a function of
time at other q-values, which report on the evolution of
different length scales during the assembly (Supplementary
Figure 6a). As described by Wallimann et al.,31 intensities
measured at two wavelengths should obey a linear relation for
a two-state system, which was not observed here (Supple-
mentary Figure 6b).
Assembly reactions were also carried out under similar
conditions but with PS RNA oligo present in the assembly
buffer. Steady-state SAXS data collected on PS RNA in
assembly buffer demonstrated that the initial state of the RNA
was a higher order assembly (Supplementary Figure 7).
Eighteen time frames were collected for the RNA series
extending up to 30 s. Up to the third time point, a decrease in
intensity at low angles was observed. One possible
interpretation of this feature was the presence of higher
order RNA structures in the assembly buffer that rapidly
disassembled after the initial mixing. The early spectra were
highly similar to those recorded in the absence of RNA and for
the steady-state dimer for q greater than ∼0.02 Å−1 (Figures 4
and 6). A second, plateauing feature was pronounced at lower
scattering angles with a second valid Guinier fit region
suggesting a small and discrete population of larger (Rg ≈
100 Å) particles (Figure 4). While this feature may be
attributed to preformed capsids, we suggest that it rather
corresponded to scattering from RNA based on the
aforementioned observation of large RNA assemblies in the
assembly buffer and decrease in forward scattering measure-
ments over the first three frames. The small Rg values were
similar to the initial assembly frames in the absence of RNA, as
shown in Figure 5. Plateaus in Dmax, Rg, and I(0)/c before the
sigmoidal transition indicated that the binding of RNA to
capsid proteins occurred very early on in the trajectory,
possibly during the delay time of the stopped-flow apparatus.
Overall, the TR-SAXS spectra in the presence of RNA
appeared very similar to the ones collected in the absence of
RNA (Figure 4). The rate of assembly was higher compared to
the RNA-free experiment (Figure 5 and Supplementary Tables
6 and 7), with midpoints between minimum and maximum
values of Rg, Dmax, and I(0)/c occurring earlier. This can be
consistently rationalized by the slightly higher protein
concentration used in the RNA experiment, which increases
the assembly rate and shortens assembly halftimes.6,9
Identification of Intermediates States with Multi-
variate Curve Resolution. SAXS spectra collected during
the assembly process can be described as a linear combination
of signals emanating from the species present in solution. To
identify intermediate states, the collection of spectra must be
deconvoluted into basis spectra that can be assigned to a single
species, or collection of species, emerging at the same time
points. A general and flexible method for deconvoluting time-
series spectra is multivariate curve resolution. In multivariate
curve resolution (MCR) a set of spectra at different time
points are described by a matrix D (with intensities as a
function of time stored as row vectors), which can be
deconvoluted as
= +D CS ET (1)
where C is a matrix of concentration profiles, S is a matrix of
basis spectra, and E is a matrix of residuals corresponding to
uncertainties of the model. In contrast to singular-value
decomposition analysis the basis components are not required
to be orthogonal, which is rarely the case. MCR has been used
previously to analyze time-resolved small- and wide-angle
scattering data.32,33 The decomposition in eq 1 does not
produce a unique solution because of rotational ambiguities
(any rotation applied to both C and S produces a new valid
solution). Additional constraints, such as assumptions about
non-negativity, unimodality, closeness, etc., must therefore be
applied. Furthermore, many alternative strategies exist for
iterative optimization of the matrices C and S that can strongly
influence the results. In order to develop an optimal analysis
strategy for this set of TR-SAXS data, scattering profiles were
simulated with noise and evaluated for the ability of MCR to
recover the correct concentration and spectral matrices. The
best performing analysis strategy involved the use of weighted
alternating least-squares (MCR-WALS) with inverse standard
errors from the experimental data as weights during the ALS.34
A fundamental assumption in any MCR analysis is that errors
for individual data points are independent. However, the highly
covarying errors at low q-values were found to have a
detrimental effect, which was resolved by removing such
points in the analysis. Constraints of non-negativity on
concentrations and spectra were also applied to reduce
rotational ambiguity. The iterative process of finding C and
S was initialized with a guess for the basis spectra through an
orthogonal projection approach (OPA), modified to recover
the correct intensity scale. This approach was shown to resolve
Figure 5. Observed rate changes derived from TR-SAXS measure-
ments after triggered self-assembly of HBV Cp185 without RNA
present (blue) and in the presence of RNA (red). Inflection points
from sigmoidal fits, without RNA: Dmax, 698 ms; Rg, 956 ms; I(0)/
c, 5.07 s; and with RNA: Dmax, 225 ms; Rg, 238 ms; I(0)/c, 3.45 s.
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Figure 6. Reconstruction of species basis spectra using a four-component MCR-WALS model without (left) and with RNA (right). Lower
panels, predicted concentration profiles for initial (blue), early intermediate (green), late intermediate (red), and final state (orange) in log
of the time scale. Upper left panel, comparison of first basis spectrum (First BS) with first time point (First TP), early intermediate basis
spectrum (Early int BS) with TP8, late intermediate basis spectrum (Late-int BS) with TP 12, and last basis spectrum (Last BS) with last
time point (Last TP). TP8 and TP12 are the time frames at the predicted concentration maximum of the intermediates. For the right RNA
panel, the basis spectra are compared to the RNA-free steady-state spectra (First and Last BS) and intermediate basis spectra. SAXS profiles
derived from structural modeling are also shown in the RNA-free panel (results described in the structural modeling section). A Bayesian
assembly model fit to TP8 (Bayesian model) and a weighted ensemble of two dimers of trimers extracted from T = 3 and T = 4 capsids is
shown (6-mers). For the late intermediate the Bayesian assembly model fit to TP12 (Bayesian model) and a calculated spectrum for an 80-
mer identified in the fitting are shown.
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mixtures of three species in the synthetic data set with very
high accuracy, in terms of both spectra and concentration
profiles (Supplementary Figure 8). When the number of
components was increased to four and the signal-to-noise
increased, the prediction of basis spectra remained highly
accurate, but small biases in the concentration profiles could
occur (Supplementary Figure 9).
Identification of Intermediate State in the Cp185
Assembly. The MCR-WALS pipeline was first applied to the
RNA-free TR-SAXS data. In the experimental data set, the
number of components was unknown and had to be estimated
from the data. A Scree plot typically used in principle
component analysis (PCA) and the Cattell−Nelson−Gorsuch
(CNG) index35 both suggested that the data could be best
described by a model of three components. This was consistent
with the quality analysis of the MCR model fit to the
experimental data as a function of number of components. A
two-component model inaccurately reconstructs the exper-
imental signal with significant deviations at intermediate time
frames (Supplementary Figure 10). With three or more
components the fit to the data was excellent, with low reduced
χ2 values (average 0.9) relative to all SAXS frames (Figure 6
and Supplementary Figure 10). However, PCA and the CNG
index can often result in underestimation of the number of
components. For example, analysis of our simulated four-
component time series (Supplementary Figure 9) would
suggest three rather than four components. When the number
of components was increased to four, an additional early
intermediate state was resolved, while the three other states
remained highly similar to those identified in the three-
component model. The profile of the early intermediate was
also consistent with our prior expectations; the concentration
was low at the beginning and the concentration profile was
unimodal without making those assumptions in the analysis.
Taken together, we suggest that the early intermediate
represented a true intermediate, and given that it appeared
early on in the assembly it could represent an assembly
nucleus.
As expected, the components that appeared first and last
during the assembly were very similar to the SAXS spectra
collected before and after assembly and thus correspond to the
dimer and capsid states (Figure 6). The concentration profiles
indicate that the initial dimer population was converted into an
early intermediate ensemble that had a maximum around 0.4 s.
The absolute-scaling-independent Mw at this time frame was
around 2.8 dimers. A late intermediate ensemble appeared next
with a maximum at around 3 s. This late intermediate
disappeared as the population of the capsid state increased. At
the predicted concentration maximum Rg was ∼120 Å and
Dmax was estimated to be 305 Å. Scale-independent Mw
determinations suggested the presence of oligomers with an
average around 30 dimers (Supplementary Table 6).
Identification of Intermediate State in Cp185
Assembly in the Presence of RNA. Next, the MCR-
WALS approach was used to assess the assembly trajectory of
Cp185 in the presence of PS RNA oligo. With three or more
components the fit to the data was excellent, with low reduced
χ2 values (average 1.0) relative to all SAXS frames (Figure 6
and Supplementary Figure 11). In the four-component model
an early intermediate was observed with a maximum around
0.3 s, while a late intermediate emerged with a maximum
around 1.4 s. Basis spectra with and without RNA appeared
highly similar at q-values above 0.020 Å−1, but differed at lower
q-values (Figure 6). This difference was attributed to RNA
binding to Cp185. One additional difference was that the
concentration profile of the late intermediate had increased
overlap with the first basis component in the presence of RNA.
Consequently, the late intermediate appeared earlier on in the
assembly reaction. Nonetheless, the overall similarities in
concentration profiles and basis spectra indicated that the
assembly passed through the same intermediate states in the
presence and absence of RNA.
Structure-Based Modeling of Self-Assembly Pathway.
One aim of this study was to attain a detailed structural
understanding of the Cp185 assembly. This remains a
challenge for a number of reasons. A TR-SAXS profile
represents rotationally averaged mixture of states, encodes a
low number of free parameters,36 and has a lower signal-to-
noise ratio than steady-state SAXS data. Care must therefore
be taken to avoid overfitting during data analysis, and
additional information must be provided to obtain a structural
model of the assembly pathway. Bayesian statistical methods
are perfectly suited to balance model complexity and fit in
these scenarios. To simplify our analysis, capsid assembly was
assumed to progress on the pathway that exclusively sampled
the icosahedral lattice as observed in the crystal structures of
Cp149 T = 337 and T = 4 HBV.24 Models of intermediates
were constructed by consecutive removal of dimers or trimers
from the full capsid models using a graph-based algorithm.
Furthermore, each monomer was modeled with a C-terminal
extension identified in the ensemble inference of the steady-
state dimer SAXS spectrum (Figure 2). To initially characterize
the RNA-free four-state model from MCR-WALS analysis,
structural ensembles were inferred using experimental data
from the SAXS frames where the concentration of the
intermediate reached a plateau (time points 7 and 8 for the
early intermediate and time points 11, 12, and 13 for the late
intermediate). Structural ensembles were determined from a
library of 360 states extracted from the T = 3 and T = 4 capsid
crystal structures containing the modeled C-terminal exten-
sions. Each state was deemed equally probable during the
initial Bayesian inference, and Bayesian model selection was
used to derive the ensemble from experimental SAXS data and
the library of structural models.25 Ensembles fit to time points
7 and 8 corresponding to the early intermediates agreed well
with the data (χ2 1.9 and 1.6) and consisted of tetramers for
TP7 and a mixture of trimers and hexamers for TP8. The
ensembles for the late intermediate (time points 11−13) fitted
well to the experimental data (χ2 ranges from 2.1 to 2.5) and
consisted of three models, which differed considerably at the
structural level. For TP11 the ensemble consisted of models
with 39, 48, and 50 monomers, for TP12 of 72, 74, and 76
monomers, and for TP13 of 84, 96, and 120 monomers. These
results suggested that the intermediate forms an ensemble of
large oligomers, but the lack of common components
highlights the difficulty of extracting unique ensembles from
individual noisy TR-SAXS frames. The same challenges were
found in the analysis of the early intermediate. By fitting
structural ensemble models to individual SAXS data frames
independently, valuable information was lost. The appearance
of a species at one time point is deemed more likely to occur if
it was found at nearby time points (for example, the ensembles
at time points 11, 12, and 13 should have contained similar
species). Consequently, each species was expected to form and
be replaced in a smooth and continuous manner. Additionally,
when all SAXS frames were independently analyzed, the
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concentration of individual species fluctuated in an unrealistic
manner (see Supplementary Figure 12), which was particularly
apparent for early time points with lower signal-to-noise ratio.
To address these issues, we extended a Bayesian ensemble
inference25 method developed for steady-state data to describe
how the ensembles evolved over time. In a Bayesian
framework, we could bias the prior probability of a species
appearing at a given time point by the probability that it was
present during the last time point. Starting from the first time
point the prior propagates from one frame to another until
reaching the last frame. The result was that all time points were
coupled together without the need for any underlying
mechanistic model of the assembly process. This naive version
has one major drawback: the end result of the ensemble
predictions was biased by significant noise in the early time
points. To reduce this bias, independent predictions for the
population of individual species were collected at all time
points. Thus, a smoothed line representing the time evolution
of each population weight was fit along the trajectory using a
Gaussian process model (Supplementary Figure 13). The
benefit of using a Gaussian process for this purpose was
threefold. First, it defined the extent of influence one time
point has on another by choosing a covariance function;
second, it acknowledged uncertainties of the inferred
population weights; and last it provided confidence intervals
to be assigned. The population weights from these smoothed
lines were then used as priors in the ensemble prediction. This
process enabled the prediction of a smooth and continuous
concentration profile for each species, where population weight
priors were influenced by predictions at all time points rather
than a single experimental data frame. Ensemble prediction
followed by population weight smoothing was then repeated
until reaching convergence. The resulting time-dependent
ensemble model reflects the number of species that can be
supported by the data and identifies major species. The true
species distribution at any given time point during the
trajectory is likely more complex, but more data (experimental
or additional modeling assumptions) would be required to
support such a model.
Structural Model of the Cp185 Assembly Pathway.
We applied this coupled Bayesian ensemble fitting model to
the empty capsid assembly data using the conformational
ensemble of 360 states extracted from the T = 3 and T = 4
capsid crystal structures and with the modeled C-terminal
extensions. Because analysis of the entire landscape of
population weights of 360 structures over the entire trajectory
was computationally intractable, the structural library was
limited to structures identified when the time frames were
independently analyzed. This restriction was supported by
observations that intermediates appeared to be on path with no
aggregation. Using the resulting structural library of 35 models
(out of 360), a structural ensemble was determined for each
time frame with concentration profiles of species modeled by
Gaussian process regression where the parameters of the
covariance function and uncertainty of inferred population
weights controlled the smoothness of the line. The estimate
from the smoothed line as prior for the next iteration was used
to repeat this process until reaching convergence. The coupling
process did not significantly influence the fit to the data as
judged by χ2 values for individual time points. The model
showed a good agreement with experimental data with χ2 of
individual data frames ranging from 2.0 to 4.8. The increase in
χ2 at later time points most likely reflects limitations in the
modeling of the C-terminal extension. The C-terminal
extensions should form an inner shell of the Cp149 capsid.
This inner shell could be partly modeled by the smaller T = 3
capsid, which is likely why the portion of T = 3 particles is
overestimated at the final time frame compared to the fraction
observed in the cryo-EM data.
The inferred pathway (Figure 7) suggests that a mixture of
dimers and hexamers existed at the early time points (up to 2
s), an intermediate state with 80 subunits (Sp80) between 2
and 40 s, and capsid-like structures at the end (mixture of T =
3, T = 4). The mixture of dimers is at its maximum at the first
time point (TP1) with a population weight of 0.65 ± 0.13
(combined from two conformations). However, the early
intermediate was dominated by a mixture of trimer of dimers
extracted from T = 3 and T = 4 capsids peaking at TP8 with a
population weight of 0.74 ± 0.14. This mixture fits well to the
Figure 7. Predicted self-assembly pathway of Cp185 in the absence
of RNA. (A) Predicted concentration profiles as a function of time
of modeled species with a population above 20% at some time
point during the trajectory. Shaded areas illustrate uncertainty in
predicting population weights using Bayesian inference. Structural
models are shown with colors matching those in the concentration
profile. Dimer (Sp2) and intermediate with 80 subunits (Sp80) are
shown with two alternative C-terminal extensions and are
superimposed on residues 1−149, while two presented hexamer
(Sp6) models were extracted from T = 3 (top) and T = 4 (bottom)
capsids. (B) χ2 values between predicted spectra from the Bayesian
assembly model and the experimental SAXS data.
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early intermediate basis spectrum identified in the four-state
MCR-WALS analysis (Figure 6). The 80-mer intermediate
adopts a partially closed shell, with two almost equally
contributing C-terminal extensions. As the dominant species
for time points 11−13 (maximum population weight 0.55 ±
0.14 at TP12), it might well correspond to the late
intermediate predicted by the MCR-WALS four-state model.
Thus, a comparison was made between the obtained basis
spectrum and the scattering profile calculated from the model
of the 80-mer. Even though deviations occurred in the high q-
region in the calculated curve, the overall profile of 80-mer
agreed quite well with the MCR-WALS basis spectrum (Figure
6). This level of similarity was unexpected because the basis
spectrum likely reflected an ensemble of species, rather than a
single structure. The mixture of capsid-like structures reaches a
maximum at the last frame (TP20) with population weights of
0.44 ± 0.09 and 0.36 ± 0.11 for Sp180 and Sp240, respectively.
Intermediates were rapidly converted into higher order
species without any indication of aggregation, which suggests
that they were on pathway. Formation of intermediates during
capsid assembly is commonly attributed to overnucleation, a
phenomenon that can be observed in both kinetic simulations
and assembly experiments. Overnucleation occurs in con-
ditions where nucleation is favored relative to elongation,
resulting in kinetically trapped intermediates due to a shortage
of free capsomers required for elongation.6,38,39 Induction of a
Cp149 assembly with high concentrations of salt11 or zinc40 or
in the presence of small-molecule assembly modifiers38 results
in overnucleation and formation of trapped intermediates
believed to be on pathway but kinetically stable. These
intermediates will eventually convert into fully formed capsids
during a slower equilibration process (sometimes over days).
This phenomenon is very different from our results on Cp185,
suggesting that overnucleation was not the mechanism behind
the formation of intermediates in this system. The results,
however, are consistent with observations from TR-SAXS
measurements on cowpea chlorotic mottle virus (CCMV),
where an intermediate with the size of a half-capsid was
inferred from the data.20
CONCLUSIONS
Our kinetic X-ray scattering data coupled to model-
independent multivariate curve resolution analysis showed
that full-length hepatitis B core protein Cp185 assembled
through a mechanism that involved two highly populated
intermediate states. Intermediates were transient, on pathway
and rapidly converted into higher order species without
formation of kinetic traps. By extending a Bayesian ensemble
modeling method to time-domain data, the evolution of a
structural ensemble was inferred without assumptions of a
specific kinetic model. The structural model suggests that
Cp185 assembles through an early intermediate largely
composed of trimers of dimers, followed by a late intermediate
ensemble dominated by a semiclosed capsid shape consisting
of 40 dimers. This structure-based assembly mechanism was in
strong agreement with the model-independent MCR-WALS
analysis. By including RNA oligos in the assembly reaction, the
influence of RNA binding on the assembly mechanism was
investigated. In the presence of an RNA oligo binding
specifically to the ARD domain of Cp the overall assembly
mechanism was not significantly altered. However, the
presence of RNA induced assembly in conditions where the
RNA-free Cp was disassembled, suggesting that RNA binding
can function as a trigger for capsid assembly.
The assembly mechanism of Cp185 shared common
features with that of Cp149: in particular the formation of
trimer of dimers that have been suggested to serve as a nucleus
for the assembly of Cp149 capsids6 and observations of a
highly populated intermediate state during Cp185 capsid
formation. Nonetheless, the overall assembly mechanism of
Cp185 capsids was considerably different. Cp149 is well
described by a two-state process, proceeding from dimers to
capsid through a series of lowly populated intermediate states.
Although aggressive assembly conditions involving high ionic
strength have been shown to result in accumulation of
intermediates, they had a broad size distribution and were
slowly converted into capsids during the assembly process.23
The presence of the flexible ARD thus has a significant impact
on the capsid assembly process, highlighting the importance of
further investigations as to how ARD modulates HBV capsid
assembly.
The in vivo capsid assembly process occurs under conditions
that are distinctly different from the ones used for in vitro
experiments. Yet the in vitro self-assembly processes studied
here described rapid kinetic trajectories that very efficiently
converted capsomers into fully formed capsids with on-path
intermediates. The in vitro assembly therefore represents a
thermodynamically and kinetically accessible pathway that
should be of relevance in understanding the more complex
assembly scenario in vivo.
METHODS
Expression and Purification of HBV Cp185. The sequence of
full-length Cp (Cp185) was based on a Cp variant with 185 residues
described by Patel et al.17 in their assessment of preferential binding
to capsid core protein using different RNA structural motifs found
within the viral pgRNA (Supplementary Figure 1). A modified
plasmid (Genscript) containing an expression vector for the Cp185
sequence was prepared in E. coli Tuner (DE3) cells (Novagen) using
standard transformation protocols. Expression conditions (time,
temperature, and IPTG concentration) and the addition of detergent
during cell lysis were investigated to optimize recovery of soluble
Cp185. SDS-PAGE gels confirmed the purity of the samples and
absence of insoluble aggregates (Supplementary Figure 2). Optimal
yields were obtained when cells were incubated in Luria broth (LB)
media supplemented with kanamycin antibiotic selection and induced
with a final concentration of 1 mM IPTG overnight at 18 °C. This
recombinantly expressed HBV Cp185 product was extracted and
isolated following purification methods described by Patel et al.17 with
a few modifications.
Following the overnight induction period, cells were pelleted via
centrifugation and the pellet was frozen at −20 °C after harvesting.
Cell pellets were thawed before lysis and resuspended with lysis buffer
consisting of 250 mM NaCl, 5 mM DTT, and 50 mM HEPES, pH
7.5, and freshly supplemented with protease inhibitor cocktail
(Roche). All purification steps were performed on ice or at 4 °C.
Cells were lysed via French press, and cellular debris removed via
centrifugation. The supernatant was then centrifuged at ultrahigh
speed overnight (120000g for ∼16 h) to pellet the soluble VLPs. After
resuspending and homogenizing the pelleted VLPs in fresh lysis
buffer, (NH4)2SO4 was slowly added to a final concentration of 20%
w/v to precipitate the HBV Cp185 proteins. Resuspension and
dialysis of the resulting precipitate was performed using disassembly
buffer consisting of 2 M GuHCl, 500 mM LiCl, 250 mM NaCl, 50
mM HEPES, pH 7.5, and 2 mM DTT and employing a two-stage
dialysis over 48 h. After removal of the final dialysis precipitates via
centrifugation, the supernatant was syringe-filtered at 0.2 μm and
separated using a Superdex 200 Increase 10/300 GL column (GE
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Healthcare), equilibrated with disassembled-state storage buffer
containing 1.5 M GuHCl, 0.5 M LiCl, 50 mM HEPES, pH 7.5, and
2 mM DTT. Fractions with a column elution volume between 15.5
and 16.5 mL corresponding to disassembled-state Cp185 were
collected for characterization and assembly reactions (Supplementary
Figure 4). The appearance of a single dominant band in SDS-PAGE
gels (Supplementary Figure 2) indicated high protein purity, and 260/
280 nm absorbance ratios (∼0.6) after SEC purification implied
negligible contamination by nucleic acids. The recovered volume
corresponds to a molecular weight (Mw) range of 20−45 kDa,
consistent with the expected Mw of ∼43 kDa for the Cp185 dimer.
Purified Cp185 can be stored in this disassembled state for up to 4
weeks at 4 °C and remains assembly competent with negligible
preformed capsids.
Preparation of HBV Cp185 Complementary-Binding RNA. A
synthetic RNA oligo was obtained from Integrated DNA Tech-
nologies, Inc. with a sequence corresponding to the HBV Cp binding
motif of design PS1 described by Patel et al.17 The 40 nt sequence
employed here was 5′-ggguuuguuuaaagacugggaggaguugggggaggagccc-
3′. The capsid assembly buffer contained 250 mM NaCl, 50 mM
HEPES, pH 7.5, and 2 mM DTT. The final concentration of RNA
used in TR-SAXS measurements was 0.075 mg mL−1, representing a
theoretical maximum binding of 1 RNA per 6.5 Cp185 monomer.
Time-Resolved Small-Angle X-ray Scattering Measure-
ments. TR-SAXS experiments were performed at the ID02 beamline
of the European Synchrotron Radiation Facility (Grenoble,
France).41,42 A Rayonix MX-170HS CCD detector with an active
area of 170 × 170 mm (pixel size 44.2 μm) and 8 × 8 binning was
used to record the 2D SAXS images. The X-ray energy and sample-to-
detector distance were 12.4 keV and 1.7 m, respectively, providing a
usable q-range from 0.008 to 0.45 Å−1. Data acquisition was triggered
by the stopped-flow device,17 with exposure times of 5 ms each.
Corrected 2D images were radially averaged to obtain the 1D
scattering profiles, and scattering from matched buffer measurements
subtracted to yield the net macromolecular scattering intensities. All
intensities are plotted as a function of the angular momentum transfer
(scattering) vector q, defined as 4π sin(θ)/λ, where 2θ is the
scattering angle.
For each set of exposures, equal volumes (200 μL) of HBV Cp185
(conditions with RNA: 1.57 mg mL−1, without RNA: 0.92 mg mL−1)
in dimer storage buffer and capsid assembly buffer (±0.15 mg mL−1
RNA PS oligo) were mixed to initiate capsid assembly by a stopped-
flow, rapid-mixing apparatus (Bio-Logic). The total mixing time was
60 ms. Initial and final conditions were also recorded using a standard
flow-through capillary with 10 frames of 0.1 s exposure times. Steady-
state (nonflowing) exposure of the sample using 20 frames of 5 ms
exposures was similarly used to assess potential radiation damage
during the stopped-flow measurements. No radiation damage was
observed over these cumulative exposures by comparing subsequent
frames.
Measurements of steady-state conditions1.14 mg mL−1 dis-
assembled protein in disassembly buffer, disassembled protein mixed
1:1 with assembly buffer >1 h after mixing, and RNA in assembly
bufferwere also collected using a standard flow-cell setup. Multiple
frames for each sample were averaged; then buffer subtracted. Outlier
frames, such as bubble flowing through cell, were identified and
excluded.
Analysis of Small-Angle Scattering Data. A Guinier
approximation of the low-q data was performed to determine
reciprocal-space values for the forward scattering, I(0), and radius
of gyration, Rg, using methods for standard compact globular particles
having a qRg upper limit defined by 1.3.
43 When appropriate based on
measurement quality, AUTORG (ATSAS) was employed.44 Calcu-
lations of equivalent real-space parameters for I(0) and Rg, as well as a
maximum particle dimension Dmax and the pairwise distance
distribution function P(r), were obtained from an indirect Fourier
transform over a broad angular range of the scattering data
(GNOM).44 Molecular weight determinations were carried out
using two absolute-scaling-independent methods, using the Porod-
invariant methods described by Rambo and Tainer45 and Piiadov et
al26 from the scattering profiles (Scatter46 and SAXSMoW26). Scatter
was used to approximate average molecular weights (number of dimer
subunits) in Supplementary Table 6. Kratky plots were prepared as
q2I(q) vs q and served as a qualitative assessment for the particle
folding. The relevant X-ray contrast values and partial specific volume
for HBV Cp185, complementary RNA, and buffer solutions were
determined from the primary structure using MuLCH (modules for
the analysis of contrast variation data).47 These physical properties are
summarized in Supplementary Table 1a.
Capsid Particle Volume Reconstruction with Cryo-Electron
Microscopy. Electron micrographs were collected using the Talos
Arctica microscope with an FEI Falcon II detector at the SciLifeLab
Swedish National Facility (Stockholm). Sample grids were treated
with a glow discharge (20 mA for 60 s) before sample application,
blotting, and plunge freezing using a Vitribot. Quantifoil 1.2/1.3 and
2.2 grid types were screened and used. Approximately 3 μL of sample
was applied before blotting with zero force under high humidity. Data
for the empty capsid condition were acquired with 92000×
magnification, 1.61 Å/pixel, a defocus range of −3.0 to −1.5, and a
total dose of 31 e− per Å2. Approximately 10k particles were extracted
from 900 micrographs. After 2D classification, 9k “capsid-like”
particles were selected, and the structures were solved using Scipion48
and Relion;49 details are found in Supplementary Table 5.
Intermediate Basis Spectra Deconvolution with Multi-
variate Curve Resolution. One-thousand synthetic TR-SAXS data
sets of assembly kinetics were simulated to identify an optimal
method to preprocess data and to find suitable parameters for the
MCR-WALS algorithm used in analysis of experimental data. In each
data set three or four high-resolution SAXS profiles with q-values in
the range [0, 0.5] Å−1 were simulated using Pepsi-SAXS9 (default
parameters except for -ns 300) and mixed with their correspondence
concentration profiles over a 20 s time window. The concentration
profiles were simulated using beta distributions with suitable shape
and scale parameters. To simulate noise with a similar pattern and
similar scale to experimental data, synthetic noise was added to each
mixed component data using the method of Sedlak and Lipfert.50 The
final synthetic data set is generated by adding a stochastic term to the
matrix of mixed components. To do so, first the intensity at each time
point is normalized (divided by I(0) and multiplied by a factor of
100) and then simulated from a normal distribution with mean I(q)
and variance σI
2(q) such that
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where τ = 0.2, k = 4500, c = 0.9, and qarb = 0.2 Å
−1.
The concentration matrix and basis spectra were identified by
weighted non-negative least-squares for the bilinear equation of MCR-
WALS by minimization of the difference between computed and
experimental (or simulated) spectra. The minimization is iteratively
run until both criteria, convergence threshold of root-mean-square
error (10−3) and minimum iterations (20), passed. Initial guesses for
the basis spectra were derived using the orthogonal projection
approach. OPA identifies the most dissimilar basis spectra in the data
set. This initial guess was provided without rescaling the intensities.
Constraints on the non-negativity of concentrations and intensities
were further employed. MCR-WALS was able to decompose the true
basis spectra when the first q-values with covariance greater than a
certain threshold were removed from the data set. As a result, the true
concentration profiles are reconstructed with little bias. The same
strategy was also employed in the analysis of experimental data sets.
Therefore, in TR-SAXS with (without) RNA, 1(4) q-values were not
considered in the deconvolution of the intermediates. The MCR-
WALS methodology was implemented in a shiny R web application,
from which readers can reproduce simulation and experimental
analysis interactively at http://shiny.andrelab.org/TR-SAXS/.
Ensemble Modeling with Rosetta and Bayesian Statistics.
One-thousand different conformations of C-terminal domain
extending from the Cp149 crystal structure (PDB code: 1QGT24)
were generated with an all-atom Monte Carlo simulation in
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Rosetta.25,51 C5 symmetry from the Cp149 crystal structure was
applied during simulation. Monomer subunits were subsequently
extracted from resulting pentamers, and models of dimers and
tetramers were created by superimposing them on the crystal
structure of Cp149. In order not to introduce symmetry bias that
may occur if monomer subunits are identical, we combined different
monomers. Therefore, the resulting dimers and tetramers are
asymmetric. Finally, we removed clashing conformations, and as a
result we obtained a structural library of 1396 models. This library was
used to fit an ensemble to the SAXS data using a Bayesian model
fitting algorithm.25 As a result, we obtained the ensemble consisting of
two dimers. These two conformations were subsequently used to
generate models of intermediates based on T = 3 (PDB code:
6BVN37) and T = 4 (PDB code: 1QGT24) capsid scaffolds. In each
iteration either a dimer (T = 4) or trimer (T = 3) was removed at the
time. Connectivity of the remaining subunits was ensured after each
iteration using a graph-based algorithm. The corresponding graphs
were created for T = 3 and T = 4 capsids using centers of masses of
building blocks (trimers or dimers) and connections to nearest
neighbors. As a result, we obtained a structural library of 360
intermediates (120 models of T = 3 and 240 models for T = 4). We
subsequently used an adapted version of a Bayesian model fitting
algorithm25 to fit ensembles to all time points. At the first step we
used Variational Bayesian Inference, which allows for the selection of
the smaller number of models representing SAXS data at each time
point. At this stage we assumed that each intermediate is equally
probable. For each time point we inferred more than one state, and
the resulting 35 models from all time points were taken to the next
step. At this stage we performed Bayesian inference using no-u-turn
Hamiltonian Monte Carlo sampling as implemented in the stan
probabilistic modeling library.52 We ran the method iteratively, and
after each iteration population weights were smoothed using Gaussian
process regression as implemented in the scikit-learn python
package.53 We used standard error of the mean from inferred
population weights to define uncertainty of input parameters for
regression. We defined the covariance function using a combination of
RBF (radial basis function) and White Kernel to provide a smooth
but not too coarse solution. In the first iteration we biased prior to the
first five time frames with weights obtained from the modeling of
steady-state dimer, and otherwise we assumed states are equally
probable. We used smoothed weights from Gaussian process
regression to bias subsequent simulations. The code for the Bayesian
inference method can be found at github.com/Andre-lab/bioce.
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